Dr. Ken Yale has joined Matria Healthcare (Marietta, Georgia) as vice president of government programs. Yale has served as senior fellow in the Center for Health Information and Decision Systems at the University of Maryland and also has led government programs at EduNeering and strategic planning at Atlantis Group for clients focusing on government programs and health information technology adoption. He also served as chief of staff to the White House Office of Science and Technology and head of the White House Domestic Policy Council. Prior to these duties, Yale was legislative counsel in the U.S. Senate and a commissioned officer in the U.S. Public Health Service. Matria Healthcare is a provider of health enhancement programs to health plans and employers.

Howard Resnick has joined MTBC (Somerset, New Jersey) as its first CFO. Resnick’s experience ranges from senior auditor at Ernst & Young to CFO of a privately held company. MTBC offers medical billing, free electronic medical records software, online access to billing and scheduling information, as well as real-time eligibility verification.

Alan Horgan has been named chief operating officerof Octagon Research Solutions (Wayne, Pennsylvania), a new position designed to drive the company’s domestic and international growth. Horgan, a pharmaceutical industry veteran with more than 25 years of experience, most recently was group vice president, late stage development, at MDS Pharma Services, a division of MDS. Octagon is a solutions provider that offers a suite of regulatory, clinical, process and information technology solutions to the life sciences industry.

Stephen Okland Jr. has been named vice president of sales for Spectranetics (Colorado Springs, Colorado). Ok-land brings to Spectranetics 18 years of experience within the medical device industry, where he has held several sales, marketing and senior management positions. During the past three years, Okland was vice president of sales and then chief operating officer at Vasca, and before that at Boston Scientific. Spectranetics manufactures single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system in conjunction with its excimer laser system.

L. David Tomei, PhD, co-founder of Xenomics (New York), has been appointed CEO of the company. Tomei will remain in his post as co-chairman. He replaces former CEO Randy White, PhD, who has left the company to pursue other interests. The company said the appointment of Tomei to the senior management position is the latest step in its strategic plan to commercialize its Transrenal-DNA (Tr-DNA) technology as a basis to develop a suite of non-invasive, DNA-based diagnostic tests for a range of major diseases, genetic disorders and other serious healthcare conditions. Tr-DNA can be obtained through urine samples.

No Comments